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Background: Surveillance of commensal  Escherichia 
coli, a possible reservoir of antimicrobial resistance 
(AMR) genes, is important as they pose a risk to human 
and animal health. Most surveillance activities rely 
on phenotypic characterisation, but whole genome 
sequencing (WGS) presents an alternative. Aim: In this 
retrospective study, we tested 515 E. coli isolated from 
pigs to evaluate the use of WGS to predict resistance 
phenotype. Methods: Minimum inhibitory concentra-
tion (MIC) was determined for nine antimicrobials of 
clinical and veterinary importance. Deviation from 
wild-type, fully-susceptible MIC was assessed using 
European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) epidemiological cut-off (ECOFF) 
values. Presence of AMR genes and mutations were 
determined using APHA SeqFinder. Statistical two-
by-two table analysis and Cohen’s kappa (k) test were 
applied to assess genotype and phenotype concord-
ance. Results: Overall, correlation of WGS with sus-
ceptibility to the nine antimicrobials was 98.9% for 
test specificity, and 97.5% for the positive predictive 
value of a test. The overall kappa score (k = 0.914) 
indicated AMR gene presence was highly predictive of 
reduced susceptibility and showed excellent correla-
tion with MIC. However, there was variation for each 
antimicrobial; five showed excellent correlation; four 
very good and one moderate. Suggested ECOFF adjust-
ments increased concordance between genotypic data 
and kappa values for four antimicrobials. Conclusion: 
WGS is a powerful tool for accurately predicting AMR 
that can be used for national surveillance purposes. 
Additionally, it can detect resistance genes from a 
wider panel of antimicrobials whose phenotypes are 
currently not monitored but may be of importance in 
the future.
Introduction
Escherichia coli  in animals comprise a diverse 
range of strains. They are a reservoir and indicator 
of antimicrobial resistance (AMR) genes that can 
be mobilised to other bacteria including zoonotic 
pathogens, and therefore pose a risk to human and 
animal health. Mobile elements such as plasmids and 
transposons are typically responsible for horizontal 
transfer of AMR genes [1,2]. Antimicrobial resistance 
can also be attributed to the expression of efflux 
pumps or single nucleotide polymorphisms (SNPs) 
present within chromosomal genes such as the DNA 
gyrase, that counteract the actions of certain antimi-
crobials [3].
Antimicrobial resistance is traditionally measured using 
phenotypic methods, for example, the minimal inhibi-
tory concentration (MIC), and interpreted using break-
points to determine resistance or susceptibility. The 
European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) sets a clinical breakpoint that deter-
mines the likelihood of therapeutic success for treating 
infection; isolates with an MIC above this level are asso-
ciated with a high level of therapeutic failure. EUCAST 
also defines an epidemiological cut-off (ECOFF) value 
which is used to differentiate the susceptible wild 
type bacterial population from non-wild type isolates 
with an acquired resistance mechanism. The European 
Union (EU) directive 2003/99/EC requests the harmo-
nised monitoring and reporting of AMR, which is coor-
dinated by the European Food Safety Authority (EFSA) 
and European Centre for Disease Prevention and 
Control (ECDC), to be carried out by EU countries for 
joint reporting of animal, food and human data [4]. The 
EU countries perform antimicrobial susceptibility test-
ing on selected pathogenic and indicator organisms, 
which include E. coli  [4,5], but no details are obtained 
on the underlying molecular mechanisms.
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Table 1
Antimicrobial resistance genes identified in Escherichia coli isolates from pooled caecal contents of healthy pigs, for nine 
antimicrobials, United Kingdom, 2018 (n = 515)
Antimicrobial class Antimicrobial AMR gene
Isolates positive for each 
gene (n)
Percentage of total 
(%)
Aminoglycosides
Apramycina and gentamicin aac3-Iva 23 4.5
Gentamicin
ant2-Ia 1 0.2
aac3-IId 23 4.5
β-lactamases
Ceftazidime and cefotaxime (also 
ampicillin)
blaCMY-2 10 1.9
blaCTX-M-1 9 1.8
blaCTX-M-15 4 0.8
blaSHV-12 5 1.0
ampC promoter -42 C→T 18 3.5
Ampicillin
blaTEM-1 6 1.2
blaTEM-135 8 1.6
blaTEM-30 5 1.0
blaTEM-1b 230 44.7
blaTEM-1c 10 1.9
blaTEM-1d 2 0.4
Phenicols Florfenicola floRb 27 5.2
Fluoroquinolones Ciprofloxacin
qnrB5 4 0.8
qnrB20 1 0.2
qnrS1 62 12.0
gyrA 
 
Ser83Leu and Asp87Asn 
 
Ser83Leu 
 
Asp87Tyr 
 
Ser83Leu and Asp87Glu 
 
Asp87Ala 
 
Asp87Asn
161 
 
80 
 
60 
 
11 
 
8 
 
1 
 
1
31.3
parC 
 
Ser80Lle 
 
Ser80Arg 
 
Ser80Arg and Glu84Lys
82 
 
80 
 
1 
 
1
15.9
parE 
 
Leu461Phe 
 
Ser458Ala
7 
 
6 
 
1
1.4
Tetracyclines Tetracycline
tetA(B) 184 35.9
tet(A) 217 43.9
tet(C) 1 0.2
tet(D) 1 0.2
tet(M) 32 6.2
Sulphonamides/ 
 
trimethoprim
Sulfamoxazole: 
 
trimethoprim (5:1)
sul1 69 13.4
sul2 181 35.2
dfrA1 66 12.8
dfrA12 94 18.3
dfrA14c 39 7.6
dfrA15 8 1.6
dfrA17 53 10.2
dfrA21 3 0.6
dfrA25 1 0.2
dfrA5 23 4.5
dfrA7 2 0.4
dfrA8 3 0.6
AMR: antimicrobial resistance.
a Apramycin and florfenicol are only used in veterinary medicine.
bfloR gene presence was determined at 99% mapping.
cdfrA14, tet(A) and tet(M) gene presence was determined at greater than 86% mapping.
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The presence of AMR genes harboured by bacteria 
can be determined by a variety of molecular methods, 
including PCR, DNA microarray and whole genome 
sequencing (WGS) [1]. Unlike PCR and microarrays, 
WGS offers the advantage of being able to screen the 
bacterial genome for multiple genes and mutations 
associated with AMR, which can be used to predict 
phenotypic susceptibility to antimicrobials [1,6] and 
to retrospectively detect newly identified AMR genes 
[7]. To identify AMR determinants, WGS data have to 
be screened against a database of AMR genes such as 
CARD or ResFinder [8,9].
In a 2017 report by EUCAST, it was stated that there 
is poor or non-existent evidence for using WGS as a 
method to infer antimicrobial susceptibility accurately 
[6]. Several recent studies have attempted to predict 
antimicrobial susceptibility from WGS data for a variety 
of bacteria, including  E. coli  [10-14]. When compared 
with phenotypic data, the predictions showed high 
concordance between genotype and phenotype with 
overall specificity and sensitivity > 95% [3]. However, 
many of these studies on  E. coli  are from clinical or 
known multidrug-resistant (MDR) isolates, and are 
limited to small panels of isolates (≤ 155).
We present an analysis on the association of gene 
presence from WGS with AMR phenotype in a large 
panel of commensal  E. coli  to predict their resistance 
to antimicrobials of human clinical and veterinary 
importance. We aimed to provide further evidence to 
support the use of WGS to enhance AMR surveillance 
and accurately predict antimicrobial susceptibility.
Methods
Bacterial isolates and antimicrobial 
susceptibility testing
In this retrospective study we compare phenotypic MIC 
values, interpreted using ECOFFs, with AMR genotypes 
in WGS data from 515 E. coli isolated from pooled cae-
cal contents of healthy pigs collected at abattoir from 
57 farms across the United Kingdom (UK) from 2014 to 
2015 [15].
Isolates were selected on Brilliance UTI Agar (Oxoid, 
Basingstoke, UK) plates containing either 1 mg/L 
cefotaxime (CTX), 1 mg/L ciprofloxacin (CIP), no anti-
biotic (NoAB) and on Brilliance carbapenem-resistant 
Enterobacteriaceae (CRE) Agar (Oxoid). The British 
Society of Antimicrobial Chemotherapy (BSAC) agar 
dilution method [16] was used to test the susceptibil-
ity of each isolate against a panel of nine antimicrobi-
als, of which two (apramycin and florfenicol) are only 
used in veterinary medicine. These antimicrobials span 
seven AMR classes of veterinary and/or human clinical 
relevance [17]: ampicillin (0.25–128 mg/L), apramycin 
(1–128 mg/L), cefotaxime (0.004–128 mg/L), ceftazi-
dime (0.004–128 mg/L), ciprofloxacin (0.004–128 
mg/L), florfenicol (0.25–128 mg/L), gentamicin (0.03–
128 mg/L), sulfamethoxazole:trimethoprim 5:1 (0.15–
640 mg/L for sulfamethoxazole and 0.03–128mg/L 
for trimethoprim) and tetracycline (0.25–128 mg/L). 
The MIC was defined as the lowest concentration that 
inhibited growth. Susceptibilities were interpreted 
using the EUCAST ECOFF values [18] because of a deci-
sion made by BSAC to migrate from BSAC to EUCAST 
methods was made after this study commenced [19]. 
Table 2
Correlation of whole genome sequencing and ECOFF or DANMAP values, test performances and kappa correlations 
for Escherichia coli isolates from pooled caecal contents of healthy pigs by antimicrobial, United Kingdom, 2018 (n = 515)
Antibiotic Ciprofloxacin Cefotaxime Ceftazidime Gentamycin Florfenicola Ampicillin Apramycina SXT Tetracycline
OverallCut-off 
(mg/L) ECOFF (> 0.06)
ECOFF 
(> 0.25) ECOFF (> 0.5) ECOFF (> 2) ECOFF (> 16)
ECOFF 
(> 8)
DANMAP 
(> 16)
ECOFF 
(> 1) ECOFF (> 8)
P+/G+ 218 45 45 45 27 283 23 258 387 1,330
P-/G- 249 464 441 468 479 218 492 209 114 3,135
G+/P- 10 1 1 0 0 2 0 15 6 34
G-/P+ 38 5 28 2 9 12 0 33 8 136
Test performances
Specificity 96.1% 99.8% 99.8% 100.0% 100.0% 99.1% 100.0% 93.3% 95.0% 98.9%
Sensitivity 85.2% 90.0% 61.6% 95.7% 75.0% 95.9% 100.0% 88.7% 98.0% 90.7%
PPV 95.6% 97.8% 97.8% 100.0% 100.0% 99.3% 100.0% 94.5% 98.5% 97.5%
NPV 86.8% 98.9% 94.0% 99.6% 98.2% 94.8% 100.0% 86.4% 93.4% 95.8%
Kappa correlations
Kappa 0.814 0.9431 0.726 0.976 0.848 0.945 1.000 0.812 0.930
DANMAP: Danish Integrated Antimicrobial Resistance Monitoring and Research Programme; ECOFF: European Committee on Antimicrobial 
Susceptibility Testing epidemiological cut-off; G+: gene/SNP present; G-: gene/SNP absent; NPV: negative predictive value; P+: phenotype 
resistant; P-: phenotype sensitive; PPV: positive predictive value; SXT: sulfamethoxazole:trimethoprim.
a Apramycin and florfenicol are only used in veterinary medicine.
Kappa correlation: almost perfect (> 0.900), strong agreement (0.800–0.900) and moderate agreement (0.600–0.790).
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Figure 1
Almost perfect correlation between phenotype and genotype of Escherichia coli isolates from pooled caecal contents of 
healthy pigs by antimicrobial, United Kingdom, 2018 (n = 515)
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ECOFF: European Committee on Antimicrobial Susceptibility Testing epidemiological cut-off; MIC: minimum inhibitory concentration.
The MIC distribution and the underlying genetic mechanisms present in isolates are shown.
Apramycin (C) is only used in veterinary medicine.
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For apramycin, there is no defined ECOFF value or 
clinical breakpoint for E. coli  so the Danish Integrated 
Antimicrobial Resistance Monitoring and Research 
Programme (DANMAP)-proposed breakpoint of > 16 
mg/L was used [20]. The definition of reduced suscep-
tibility refers to isolates with an MIC above the ECOFF 
value and susceptible isolates refers to isolates with 
an MIC equal to or less than the ECOFF value.
Whole genome sequencing
DNA was extracted and Illumina HiSeq 4000 System 
whole genome sequencing (WGS) (Illumina, San Diego, 
United States (US)) performed on the  E. coli  isolates 
and sequences were deposited in the European 
Nucleotide Archive (ENA) under study accession number 
PRJEB26317. The APHA SeqFinder pipeline was used to 
determine the presence of 2,044 AMR genes, including 
genes associated with the nine antimicrobials tested in 
this study [7]. Presence of AMR genes belonging to each 
AMR class considered was determined by mapping 
unassembled reads to a database of gene sequences, 
following quality control measurements described pre-
viously [7]. An AMR gene was considered present if there 
was 100% gene mapping to the reference in the APHA 
SeqFinder database of AMR genes, allowing up to 10 
non-synonymous SNPs, with the exception of floR that 
was present at 99% gene mapping and dfrA14, tet(A) a
nd  tet(M)  that were present at greater than 86% gene 
mapping. Genome assembles were generated using 
SPAdes version 3.7.0 [21] and AMR gene presence was 
corroborated using abricate (https://github.com/tsee-
mann/abricate) [21]. To identify SNPs in chromosomal 
genes/regions,  gyrA,  parC,  parE  and  ampC  promoter, 
associated with resistance (cSNP-AMR), ClustalW gene 
alignments were performed in DNASTAR Lasergene 11 
Core Suite (DNASTAR Inc, Madison, US) and these were 
then incorporated into the APHA SeqFinder pipeline. E. 
coli strain K12 MG1655 was used as the reference.
Statistical analysis
The correlation between the presence/absence of AMR 
genes and/or associated SNPs from the WGS results 
and the susceptibility by MIC phenotypes was evalu-
ated statistically by two-by-two table analysis, as 
performed previously for other phenotype/genotype 
correlations [22,23] where test specificity, sensitivity 
and the positive predictive value (PPV) and negative 
predictive value (NPV) of the test were calculated using 
the following criteria: (i) correlation between WGS-
gene presence and MIC-resistant results as true posi-
tive (TP), (ii) WGS-negative and MIC-susceptible results 
as true negative (TN), (iii) WGS-gene presence but MIC-
susceptible results as false positive (FP) and (iv) WGS-
negative but MIC-resistant results as false negative 
(FN). The capability of the MIC and WGS for identifying 
AMR was compared using the Cohen’s kappa test (κ), 
which is a measure of agreement above that expected 
by chance, with a κ of 0 indicating that the test agrees 
as well as would be expected by chance, and a κ of 
1 indicating complete agreement. When assessing the 
kappa test, a result of above 0.900 was interpreted 
as almost perfect, 0.800–0.900 as strong agreement, 
0.600–0.790 as moderate agreement, 0.400–0.590 as 
weak agreement and 0.200–0.390 as minimal agree-
ment [24].
Results
Minimum inhibitory concentration phenotype
Of 515  E. coli  tested, only 56 isolates (11%) were 
susceptible to all antimicrobials tested, with the 
remaining isolates resistant to between one and seven 
antimicrobials. The most common reduced susceptibility 
was observed for tetracycline (77%, n = 395), ampicillin 
(57%, n = 295) and sulfamethoxazole:trimethoprim 
(57%, n = 291). The least common reduced susceptibil-
ity was detected for the two veterinary antimicrobials 
included, florfenicol (7%, n = 36) and apramycin (4.5%, 
n = 23).
Antimicrobial resistance genotype
Seventy-eight of 515 isolates (15%) had no detectable 
AMR genes or cSNP-AMR present in our database, with 
the remaining isolates having between one and nine 
acquired AMR genes and/or cSNP-AMR associated with 
the antimicrobials tested. Approximately 55% (n = 283) 
of isolates harboured between three and seven AMR 
genes and/or cSNP-AMR showing a multidrug resist-
ance genotype, with seven isolates harbouring geno-
typic resistances to all seven antimicrobial classes 
tested. The most common AMR genes included  blaTEM-
1b (45%), tet(A) (44%) and tetA(B) (36%) (Table 1), which 
corresponded with the high levels of reduced suscep-
tibility to ampicillin and tetracycline detected by MIC .
Genotypic prediction of resistance phenotype
The relationship between genotype and phenotype 
was evaluated for the nine antimicrobials using the 
gene categories given in  Table 1. Using the ECOFF 
value, overall correlation of WGS with MIC was 99% for 
test specificity and 98% for the tests’ PPV (Table 2). 
The kappa values for each antimicrobial tested ranged 
from 0.726 to 1.000, and predominantly showed strong 
agreement (κ > 0.800) between gene presence and 
reduced susceptibility (Table 2). The overall kappa 
score (κ = 0.914) indicated that WGS gene presence was 
highly predictive of reduced susceptibility and showed 
‘almost perfect’ agreement with phenotypic MIC data 
from isolates. Test sensitivity was 91%, which although 
lower than test specificity, still showed strong agree-
ment and could be because of the presence of yet 
unknown genes/mechanisms that were absent from 
our database.
Almost perfect agreement, kappa value > 0.900
Five antimicrobials (ampicillin, cefotaxime apramy-
cin, gentamicin and tetracycline) showed almost per-
fect agreement (κ > 0.900) between phenotype and 
genotype. Fifty-seven percent of total  E. coli  isolates 
(n = 295) had reduced susceptibility to ampicillin, and 
96% showed (n = 283) correlation with a resistance 
genotype; isolates harboured one or more β-lactamase 
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resistance genes and/or a chromosomal ampC promoter 
mutation (Table 1,  Figure 1A). Two isolates were phe-
notypically susceptible to ampicillin but harboured 
β-lactamase resistance genes; one isolate contained 
a  blaCTX-M-1  but was susceptible to ampicillin (MIC: 4 
mg/L), ceftazidime (MIC: 0.5 mg/L) and cefotaxime 
(MIC: 0.125 mg/L), and the other ampicillin suscepti-
ble isolate (MIC: 2 mg/L) possessed two blaTEM variants 
(blaTEM-1b and blaTEM-30 ). For cefotaxime, 50 of 515 isolates 
(10%) had reduced susceptibility by ECOFF, of which, 
45 isolates harboured a genetic resistance determinant 
present in our APHA SeqFinder database (Figure 1B). 
Twenty-seven isolates harboured transferable extended 
spectrum β-lactamase (ESBL) resistance genes (Table 
1) and 18 contained the chromosomal  ampC  promoter 
mutation, which can lead to mutational de-repression 
or constitutive expression of AmpC [25]. The remain-
ing five isolates showing reduced susceptibility (MIC: 
0.5–2 mg/L), did not harbour an ESBL gene or chromo-
somal mutation in the ampC promoter.
For apramycin, using the DANMAP proposed break-
point, there was 100% agreement between the phe-
notype and genotype; 23 isolates showed reduced 
susceptibility (MIC: ≥ 128 mg/L) and harboured 
the aac3-Iva gene (Figure 1C). Similarly for gentamicin 
there was almost perfect correlation (κ = 0.976), where 
45 of 47 isolates with reduced susceptibility harboured 
Figure 2
Strong and moderate correlation between phenotype and genotype of Escherichia coli isolates from pooled caecal contents of 
healthy pigs by antimicrobial, United Kingdom, 2018 (n = 515)
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The MIC distribution and the underlying genetic mechanisms present in isolates are shown.
Florfenicol (C) is only used in veterinary medicine.
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a gentamicin resistance gene (Figure 1D). A further two 
isolates with reduced susceptibility (MIC: ≥ 16 mg/L) 
did not harbour a gentamicin resistance gene; these 
isolates also showed reduced susceptibility to ampi-
cillin (MIC: ≥ 128 mg/L), florfenicol (MIC: ≥ 64 mg/L) 
and sulfamethoxazole:trimethoprim (MIC: > 128 mg/L), 
but did not harbour the associated resistance genes, 
suggesting a possible alternative multidrug resistance 
mechanism, such as efflux.
Reduced susceptibility to tetracycline was the most 
common in our E. coli collection (77%, n = 395 isolates), 
and we were able to correlate this with a resistance 
genotype in 387 isolates which harboured a tet variant 
gene (Figure 1E). Six phenotypically susceptible iso-
lates also harboured a  tet  variant, four of these were 
at the ECOFF value (MIC: 8 mg/L) and harboured 
either tet(A) or tet(C); two isolates with a MIC between 
1 and 2 mg/L harboured  tet(M), which is common in 
Gram-positive bacteria but has also been reported 
from E. coli and Salmonella [26,27].
Strong agreement, kappa value 0.800 to 0.900
Three antimicrobials (ciprofloxacin, 
sulfamethoxazole:trimethoprim and florfenicol) 
showed very strong agreement (κ = 0.812 to 0.848) 
between the genotype and phenotype. Fifty percent 
(n = 256) of isolates showed reduced susceptibility to 
ciprofloxacin; 218 of these harboured a plasmid medi-
ated quinolone resistance (PMQR) gene (26%, n = 57) 
and/or SNPs in the quinolone resistance determining 
regions (QRDR) of gyrA or parC (74%, n = 161). We noted 
that the MIC of isolates harbouring PMQR genes only 
(n = 57) was between 0.125 and 8mg/L, while those 
with QRDR mutations only (n = 152) ranged between 
0.125 and 128mg/L. In the remaining 38 isolates 
with reduced susceptibility, no genotypic resistance 
mechanism was identified. Ten isolates were suscep-
tible to ciprofloxacin but harboured genetic determi-
nants; nine harboured mutations in the QRDR and one 
isolate harboured  qnrS1  and was at the ECOFF value 
(Figure 2A).
For sulfamethoxazole:trimethoprim, 57% isolates 
(n = 291) showed reduced susceptibility with 258 of these 
harbouring a dfr variant alone (n = 90) or in combination 
with a sul (n = 168). Two isolates had a sul variant alone 
(Figure 2B). For the remaining 31 isolates with reduced 
susceptibility to sulfamethoxazole:trimethoprim, no 
significant match with genetic determinants in our 
database were detected. As presence solely of dfr or in 
combination with sul resulted in reduced susceptibility; 
for phenotype and genotype correlation, these combi-
nations were included and resulted in strong agree-
ment (κ = 0.812). Fifteen susceptible isolates (5%) 
harboured a  dfr  gene alone (n = 10) or in combination 
with a  sul  (n = 5), seven of these were at the ECOFF (1 
mg/L), and 37 susceptible isolates only harboured 
a sul variant.
Florfenicol is an antimicrobial solely used in veterinary 
medicine, and 36 isolates showed reduced suscep-
tibility and resulted in strong agreement (κ = 0.848). 
The floR gene was present in 27 of these isolates with 
MIC > 32 mg/L, but in the remaining nine, no florfeni-
col resistance determinants were detected (Figure 2C). 
We noted that isolates harbouring cml or catA1 genes, 
which are associated with chloramphenicol resistance, 
did not confer cross-resistance to florfenicol, typically 
showing MIC value < 32 mg/L (data not shown).
Moderate agreement, kappa value 0.600 to 
0.799
The lowest agreement was observed with ceftazi-
dime (κ = 0.726); 73 isolates (14%) showed reduced 
susceptibility using ECOFF, but only 45 isolates harboured 
an ESBL gene or chromosomal  ampC  promoter 
mutation. The remaining 28 isolates did not harbour 
a resistance gene or chromosomal changes present in 
our database (Figure 2D).
Effect of adjusting the epidemiological cut-off
For florfenicol, others [28,29] have suggested a ECOFF 
value for  E. coli  isolates tested from swine and cattle 
of > 32 mg/L as an alternative to the current one at > 16 
mg/L. When the higher MIC cut-off value was applied 
to our dataset only 31 of 515 (6%) isolates showed 
reduced phenotypic susceptibility, and reduced the 
number of false negative isolates to four. The higher 
cut-off value also improved sensitivity and raised 
kappa correlation for florfenicol to the almost perfect 
correlation category, from 0.848 to 0.927. A similar 
scenario was observed for tetracycline where lower-
ing cut-off value from > 8mg/L to > 4 mg/L, (Figure 1E) 
increased the kappa correlation from 0.930 to 0.945 so 
only two isolates were false positive. For eight isolates, 
the correlation did not change; they remained as false 
negative.
For sulfamethoxazole:trimethoprim, the MICs were 
determined using a 5:1 ratio that is relevant for veteri-
nary medicine [30], however, the ECOFF value is based 
on a 19:1 ratio as used in human clinical settings. Based 
on the ratio of 5:1 sulfamethoxazole:trimethoprim 
used, we suggest that a lower ECOFF value of > 0.5 
mg/L is more appropriate for the methodology applied 
here and will need to be tested for wider application 
(Figure 2B). However, its application increased the 
number of isolates with reduced susceptibility from 
291 to 300 (58%), with 210 of these isolates contain-
ing a dfr variant. As a result, the number of susceptible 
isolates harbouring a  dfr  gene halved, improving the 
kappa agreement between MIC phenotype and WGS 
gene presence from 0.812 to 0.836. For ceftazidime, 
comparison of the MIC with WGS at a slightly higher 
cut-off of > 1 mg/L (Figure 2D) improved the kappa cor-
relation, from 0.726 to 0.889, because of a decrease in 
the number of false negative isolates.
Using the ECOFF cut-off values, the number of iso-
lates that showed complete phenotype/genotype 
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concordance for all nine antimicrobials in their suscep-
tibility profile was 394 (77%). For the remaining 121 iso-
lates, there were discrepancies (false positive or false 
negative results) in up to five antimicrobials. Using 
the adjusted cut-off values for the four antimicrobials 
above, the numbers of isolates with genotype/phe-
notype concordance for all nine antimicrobials across 
their susceptibility profile increased to 419 (81%), with 
the number of discrepant isolates decreasing to 96.
Discussion
In this study, we explored the use of WGS data as an 
alternative to the traditional phenotypic method, MIC, 
used to determine AMR. At the time of this study, the 
BSAC agar dilution MIC was the accepted method for 
determining susceptibility, and in 2016, BSAC migrated 
to the EUCAST broth microdilution method in order to 
harmonise resistance prediction interpretations across 
Europe [19]. For this reason, EUCAST ECOFF values 
were applied to our data. A future study comparing the 
genotype results with phenotypes derived from broth 
microdilution would be of interest. However, as there 
was almost perfect agreement between WGS and MIC 
for the majority of antimicrobials when ECOFF values 
were used with agar dilutions, the improvements may 
or may not be substantial when using broth microdilu-
tions. Additionally, there were no considerable changes 
to the kappa values obtained in this study when isolate 
WGS data were tested with other AMR pipelines avail-
able (data not shown).
Sulfamethoxazole:trimethoprim, florfenicol, ceftazi-
dime and ciprofloxacin, which had the poorest agree-
ment, nevertheless showed strong to moderate kappa 
values. However, when the ECOFF value was adjusted 
for several aforementioned antimicrobials, following 
analysis of the MIC distribution with gene presence, we 
noted an improvement in the kappa correlation, i.e. an 
increase in the number of isolates that were true posi-
tives and true negatives. The majority of discrepancies 
in our results were because of false negative correla-
tions, i.e. isolates with reduced susceptibility lacking 
a relevant genetic resistance determinant from our 
database, suggesting that unknown resistance genes 
may be present in these bacteria. However, the over-
all WGS/MIC specificity of 99%, the predictive value of 
a positive test being 98% and a kappa value of 0.930 
was encouraging, and adds to the growing number 
of studies recommending the use of AMR genotyping 
[10,12-14].
In other studies where E. coli WGS was compared with 
phenotype [10,12,13], reported discrepancies mainly 
included phenotypically-susceptible isolates harbour-
ing a resistance gene. In this study, a small number 
of such false positive isolates (14/31) had an MIC at 
or below the ECOFF value; this was most commonly 
observed for sulfamethoxazole:trimethoprim and cipro-
floxacin. In the case of sulfamethoxazole:trimethoprim, 
determining the phenotype from genotype was com-
plicated by the different mechanisms of resistance, 
including the expression of efflux pumps and cell wall 
permeability [31].
This study focused on known acquired resistance deter-
minants. However, there are a number of other chromo-
somal genes where SNPs and variations in expression 
could result in resistance, e.g.  folA-encoding dihydro-
folate reductase for trimethoprim [11], or expression 
of multidrug efflux systems such as the  mar  operon 
[32,33], that were not investigated and could explain 
some of the false negative results that were obtained. 
Also, there may be improvement in phenotypic and 
genotypic correlations if an ECOFF was attained appro-
priate for the 5:1 ratio used in veterinary medicine. 
Other limitations of the WGS approach are that only 
known genes can be determined [1,6] and that it does 
not take genes that may be present but not expressed 
or the effect of multiple resistance genes present for 
the same class of antimicrobial into account [34].
However, WGS can be used to identify the presence 
of novel-acquired mechanisms to explain discrepan-
cies, for example the identification of the pleuromu-
tilin resistance gene  tva(A) in  Brachyspira  spp. [35]. 
New resistance mechanisms can be added to the AMR 
database and the WGS can be screened again to per-
form retrospective analysis once new/novel genes are 
detected, as shown following  mcr  detection in 2015 
[36]. Therefore, isolates found to have moderate kappa 
correlations in this study may be harbouring novel 
genes/mechanisms that require further investigation.
The EUCAST report on the role of WGS in AMR sus-
ceptibility testing of bacteria recommended that the 
primary MIC comparator for WGS predictions be the 
ECOFF, but it encouraged using the clinical breakpoints 
as a secondary comparator, acknowledging that doing 
so would be more challenging with our current knowl-
edge [6]. Although our study found almost perfect cor-
relation (κ > 0.9) between phenotype/genotype for most 
of the antimicrobials considered using ECOFF cut-offs, 
clinical breakpoints available for four antimicrobials 
showed much lower correlation (Supplementary Table 
S1). Clinical breakpoints are based on the success of 
treatment and therefore factors other than the MIC dis-
tribution alone are taken into consideration, e.g. host, 
clinical treatment data and pharmacokinetics of the 
drug [37]; properties that cannot be predicated from 
bacterial genome sequence alone.
WGS also provides the potential to predict susceptibil-
ity to a wider range of antimicrobials, including those 
not routinely tested in MIC panels. The APHA SeqFinder 
pipeline screens for 2,044 genes. In addition to the 
genes associated with the nine antimicrobials tested 
in this study (Table 1), a further 29 genes with pre-
dicted reduced susceptibility to other aminoglycosides 
(aac6-IId,  aad(various),  ant3–1a,  aph3,  aph4,  strA 
and  strB  genes), chloramphenicol (cml, cat), strep-
tothricin (sat2) and macrolides (ermB,  inuF,  mefB 
and mphA and mphB) were also detected in the 515 E. 
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coli  isolates. WGS data can also be used to provide 
further information on strains, including the multilo-
cus sequence types, phylogeny, plasmids and plasmid 
types [36] that are important in assessing transmission 
of AMR. However, standardisation of WGS methodolo-
gies and analysis of the data is required before this 
technology is applied in AMR reference laboratories for 
routine surveillance activities.
In conclusion, the results of this study demonstrate 
that the use of WGS, a technological advancement 
over traditional phenotyping, should be considered 
an alternative way to monitor antimicrobial resistance 
in bacteria by national and pan-European surveillance 
programmes.
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